Better Buy: Ziopharm Oncology, Inc. vs. bluebird bio Inc. – Yahoo News
Yahoo News |
Better Buy: Ziopharm Oncology, Inc. vs. bluebird bio Inc.
Yahoo News Chimeric antigen receptor T–cell (CAR-T) therapies and gene therapies are hot commodities these days. But some small biotechs developing CAR-T drugs and gene therapies are hotter than others. Over the last 12 months, bluebird bio (NASDAQ: BLUE) … |
